Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$771,849
+$253,236 QoQ
Shares Held
135,889
+12.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#92
of 242 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEXFORD CAPITAL LP holds $6,414,779 across 8 Biotechnology names. NUVB ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
90,752 | $1,692,524 | |
| 2 | TSHA |
Taysha Gene Therapies, Inc.
|
160,654 | $1,094,053 | |
| 3 | NUVB |
Nuvation Bio Inc.
This page
|
135,889 | $771,849 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
13,709 | $735,762 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
2,000 | $669,580 | |
| 6 | PTHS |
Pelthos Therapeutics Inc.
|
22,364 | $632,006 | |
| 7 | ARGX |
Argenx SE
|
500 | $463,885 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
4,000 | $355,120 |
All Filings in NUVB
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $771,849 | 135,889 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $518,613 | 120,889 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,164,800 | 130,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $112,213 | 30,328 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $159,100 | 81,590 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,360,337 | 772,919 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,516,942 | 946,219 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,492,546 | 651,767 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $184,739 | 63,267 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $92,037 | 25,285 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,135 | 13,997 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $52,396 | 39,102 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $46,260 | 25,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $162,079 | 97,638 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $44,160 | 23,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||